Brief: Entrada Therapeutics Reports First Quarter 2022 Financial Results
12/05/2022 12:09
May 12 (Reuters) - Entrada Therapeutics Inc TRDA.O :
* ENTRADA THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
* ENTRADA THERAPEUTICS INC - CASH, CASH EQUIVALENTS AND
MARKETABLE
SECURITIES WERE $263.9 MILLION AS OF MARCH 31, 2022
* ENTRADA THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.69
Source text for Eikon: ID:nGNX34cTRL
Further company coverage: TRDA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entrada Therapeutics
See all newsBrief: Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Entrada Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Entrada Therapeutics Q2 Collaboration Revenue USD 898 Thousand
Entrada Therapeutics Q2 net loss narrows on lower costs
Entrada Therapeutics Inc expected to post a loss of $1.05 a share - Earnings Preview